Chris Mühlhausen

Chris Mühlhausen

Auto-generated profile, based on publicly available information

Chris Mühlhausen

Department of Pediatrics and Adolescent Medicine, University Medical Center, Göttingen, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Cell Metabolism
Verified
Journal Article
Closed access
MTMinjia Tan
Minjia Tan
CPChao Peng
Chao Peng
KAKristin A. Anderson
Kristin A. Anderson
PCPeter Chhoy
Peter Chhoy
ZXZhongyu Xie
Zhongyu Xie
YZYingming Zhao
Yingming Zhao

23 March 2011 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
PDF file
SKStefan Kölker
Stefan Kölker
ECErnst Christensen
Ernst Christensen
JLJames V. Leonard
James V. Leonard
CGCheryl R. Greenberg
Cheryl R. Greenberg
ABAvihu Boneh
Avihu Boneh
PBPeter Burgard
Peter Burgard
Glutaric aciduria type I (synonym, glutaric acidemia type I) is a rare organic aciduria. Untreated patients characteristically develop dystonia during infancy resulting in a high morbidity and mortality. The neuropathological correlate is striatal injury which results from encephalopathic crises precipitated by infectious diseases, immunizations and surgery during a finite period of brain development, or develops insidiously without clinically apparent crises. Glutaric aciduria type I is caused by inherited deficiency of glutaryl‐CoA dehydrogenase which is involved in the catabolic pathways of L‐lysine, L‐hydroxylysine and L‐tryptophan. This defect gives rise to elevated glutaric acid, 3‐hydroxyglutaric acid, glutaconic acid, and glutarylcarnitine which can be detected by gas chromatography/mass spectrometry (organic acids) or tandem mass spectrometry (acylcarnitines). Glutaric aciduria type I is included in the panel of diseases that are identified by expanded newborn screening in some countries. It has been shown that in the majority of neonatally diagnosed patients striatal injury can be prevented by combined metabolic treatment. Metabolic treatment that includes a low lysine diet, carnitine supplementation and intensified emergency treatment during acute episodes of intercurrent illness should be introduced and monitored by an experienced interdisciplinary team. However, initiation of treatment after the onset of symptoms is generally not effective in preventing permanent damage. Secondary dystonia is often difficult to treat, and the efficacy of available drugs cannot be predicted precisely in individual patients. The major aim of this revision is to re‐evaluate the previous diagnostic and therapeutic recommendations for patients with this disease and incorporate new research findings into the guideline.

15 April 2015 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
SKStefan Kölker
Stefan Kölker
ACAngeles Garcia Cazorla
Angeles Garcia Cazorla
VVVassili Valayannopoulos
Vassili Valayannopoulos
ALAllan M Lund
Allan M Lund
ABAlberto B. Burlina
Alberto B. Burlina
PBPeter Burgard
Peter Burgard

16 November 2016 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
NBNikolas Boy
Nikolas Boy
CMChris Mühlhausen
Chris Mühlhausen
EMEsther M. Maier
Esther M. Maier
JHJana Heringer
Jana Heringer
BABirgit Assmann
Birgit Assmann
ACAdditional Individual Contributors
Additional Individual Contributors

11 May 2009 in Brain
Verified
Journal Article
Open access
PDF file
IHInga Harting
Inga Harting
ENEva Neumaier-Probst
Eva Neumaier-Probst
ASAngelika Seitz
Angelika Seitz
EMEsther M. Maier
Esther M. Maier
BABirgit Assmann
Birgit Assmann
SKStefan Kölker
Stefan Kölker
In glutaric aciduria type I, an autosomal recessive disease of mitochondrial lysine, hydroxylysine and tryptophan catabolism, striatal lesions are characteristically induced by acute encephalopathic crises during a finite period of brain development (age 3–36 months). The frequency of striatal injury is significantly less in patients diagnosed as asymptomatic newborns by newborn screening. Most previous studies have focused on the onset and mechanism of striatal injury, whereas little is known about neuroradiological abnormalities in pre-symptomatically diagnosed patients and about dynamic changes of extrastriatal abnormalities. Thus, the major aim of the present retrospective study was to improve our understanding of striatal and extrastriatal abnormalities in affected individuals including those diagnosed by newborn screening. To this end, we systematically analysed magnetic resonance imagings (MRIs) in 38 patients with glutaric aciduria type I diagnosed before or after the manifestation of neurological symptoms. To identify brain regions that are susceptible to cerebral injury during acute encephalopathic crises, we compared the frequency of magnetic resonance abnormalities in patients with and without such crises. Major specific changes after encephalopathic crises were found in the putamen (P < 0.001), nucleus caudatus (P < 0.001), globus pallidus (P = 0.012) and ventricles (P = 0.001). Analysis of empirical cumulative distribution frequencies, however, demonstrated that isolated pallidal abnormalities did not significantly differ over time in both groups (P = 0.544) suggesting that isolated pallidal abnormalities are not induced by acute crises––in contrast to striatal abnormalities. The manifestation of motor disability was associated with signal abnormalities in putamen, caudate, pallidum and ventricles. In addition, we found a large number of extrastriatal abnormalities in patients with and without preceding encephalophatic crises. These abnormalities include widening of anterior temporal and sylvian CSF spaces, pseudocysts, signal changes of substantia nigra, nucleus dentatus, thalamus, tractus tegmentalis centralis and supratentorial white matter as well as signs of delayed maturation (myelination and gyral pattern). In contrast to the striatum, extrastriatal abnormalities were variable and could regress or even normalize with time. This includes widening of sylvian fissures, delayed maturation, pallidal signal changes and pseudocysts. Based on these results, we hypothesize that neuroradiological abnormalities and neurological symptoms in glutaric aciduria type I can be explained by overlaying episodes of cerebral alterations including maturational delay of the brain in utero, acute striatal injury during a vulnerable period in infancy and chronic progressive changes that may continue lifelong. This may have widespread consequences for the pathophysiological understanding of this disease, long-term outcomes and therapeutic considerations.

29 March 2006 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
SSSven W. Sauer
Sven W. Sauer
JOJürgen G. Okun
Jürgen G. Okun
Gert FrickerGert Fricker
Gert Fricker
AMAnne Mahringer
Anne Mahringer
IMInes Müller
Ines Müller
SKStefan Kölker
Stefan Kölker